InVita Healthcare Technologies Brings Industry First Driver Mobile App to Blood Centers

InVita Healthcare Technologies, a leader in chain of custody software technologies for complex medical environments, including blood and plasma collection, forensic lab and hospital, announces the first native mobile app for blood product deliveries. InVita’s HemaControl Driver App tracks blood products in transit from the blood center to the final destination at the hospital. Using Title 21 CFR Part 11 digital signature technology, the HemaControl Driver App eliminates paper, provides transparency to all parties on product deliveries, and overlays product pickups and deliveries with GPS traffic data to avoid transportation delays and reduce transportation costs.

Recommended AI News: Venzee Automates Hardline Retail Product Data Flow for New Brand Client

InVita’s HemaControl Driver App’s paper-free environment ensures an audit trail with timestamp recording and complete documentation that isn’t always successfully executed through manual systems. With the benefits of HemaControl, stakeholders across the supply chain receive immediate notification of delivery, where the delivery was made, and who signed for it. Hospital partners gain visibility into the timing of all orders, including STAT, ASAP, and specialty orders for patients in need. Blood center operations gain immediate efficiencies—reduced time spent on paper processes, best traffic routes, and chain of custody tracking—that are vital to increasing speed, delivery transparency, and lowering the costs of blood product transportation.

LifeSouth Community Blood Centers, one of the largest U.S. blood centers, rolled out the HemaControl Driver App across all delivery operations. “Transportation and movement of blood products is an important aspect of our operations,” said J.D. Pettyjohn, Chief Operating Officer at LifeSouth. “The driver app adds efficiencies and transparency throughout the process, making it easy to close out orders quickly and monitor the status of our deliveries.”

Recommended AI News: Keeps Launches Crowd DeFi Service

“HemaControl is the only system that can efficiently manage all the moving parts of blood product fulfillment—order receipt, product packaging, transport, delivery receipt, specimen pickups, and mid-day drive data,” said Todd Collins, President and CEO of InVita. “Without HemaControl and the driver mobile app, there’s no transparency or chain of custody between blood centers and their hospital partners. Inconsistent or absent documents, delays due to traffic conditions, and orders with inaccurate or no delivery timestamp become culprits for higher costs. HemaControl addresses these challenges affordably and removes the gaps caused by paper processes and lack of visibility that lead to higher costs.”

Since 2013, HemaControl has been the leading hospital order entry and inventory management system. With robust GPS order tracking via the driver native mobile app, there’s transparency in hospital blood orders from order to fulfillment to delivery receipt at the hospital. HemaControl also integrates with other InVita products, including donor recruitment and engagement (HemaConnect), staffing and mobile drive management (HemaCollect), product QC (HemaComply–Lab), and equipment maintenance (HemaComply–Equipment Manager).

Recommended AI News: Blockchain Marketing Agency Hype Partners Acquires DeFi Consultancy agency0x